+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The use of epsilon aminocaproic acid in sickle cell trait hematuria



The use of epsilon aminocaproic acid in sickle cell trait hematuria



Journal of Urology 105(4): 552-553




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 027750753

Download citation: RISBibTeXText

PMID: 4997398

DOI: 10.1016/s0022-5347(17)61574-x


Related references

Sickle cell hematuria controlled by epsilon aminocaproic acid. Connecticut Medicine 39(12): 777-778, 1975

Epsilon aminocaproic acid therapy of hematuria due to heterozygous sickle cell diseases. Journal of Urology 102(1): 93-95, 1969

The effect of bicarbonate and distilled water on sickle cell trait hematuria and in vitro studies on the interaction of osmolality and pH on erythrocyte sickling in sickle cell trait. Journal of Urology 118(5): 793-796, 1977

Epsilon-aminocaproic acid in traumatic renal hematuria in the rabbit. Investigative Urology 12(6): 458-460, 1975

Unilateral essential hematuria. Therapy with epsilon aminocaproic acid. Urology 23(3): 297-298, 1984

Urinary incidents in the treatment of hematuria in hemophiliacs with epsilon-aminocaproic acid. Lille Medical 13(4): 408-412, 1968

Successful epsilon-aminocaproic acid therapy in a patient with unexplained hematuria. Clinical Pediatrics 16(2): 167-168, 1977

Treatment with epsilon aminocaproic acid in persistent hematuria after renal punch biopsy. Semaine Therapeutique 40(4): 273, 1964

Renal complications during treatment of hematuria in hemophilia A with epsilon-aminocaproic acid (EACA). Polski Tygodnik Lekarski 26(4): 145-147, 1971

Treatment of hematuria in a hemophiliac by epsilon aminocaproic acid with concomitant urokinase determination. Bibliotheca Haematologica 26: 114-114, 1966

Incidence of thrombosis associated with epsilon-aminocaproic acid administration and with combined epsilon-aminocaproic acid and subcutaneous heparin therapy. II. A clinical study with the aid of intravenous phlebography. Acta Chirurgica Scandinavica 136(3): 167-171, 1970

Incidence of thrombosis associated with epsilon-aminocaproic acid administration and with combined epsilon-aminocaproic acid and subcutaneous heparin therapy. A study in experimental animals and in clinical material. Acta Chirurgica Scandinavica 134(5): 343-349, 1968

Comparative Study on the Effect of Epsilon-Aminocaproic Acid, Acetyl-Epsilon-Aminocaproic Acid and Caprolactam for Various Parameters of the Fibrinolytic System. Wiener Medizinische Wochenschrift 115: 102-105, 1965

The Use of Epsilon Aminocaproic Acid, a Potent Inhibitor of Fibrinolytic Activity, in the Management of Postoperative Hematuria. Journal of Urology 86(6): 829-837, 1961

Arteriovenous fistula and prolonged hematuria after renal biopsy: treatment with epsilon aminocaproic acid. Canadian Medical Association Journal 110(6): 671, 1974